Sarepta Therapeutics: Pay

Sarepta Therapeutics paid its 6 named executives $26.9M in total in FY2025 (Dec). CEO Douglas S. Ingram was paid $7.8M of that.

Pay$100 in the stock at the end of FY20 → $13
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Douglas S. IngramChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Louise Rodino-Klapac, Ph.D.President, Research and Development and Technical Operations
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Ian M. EstepanPresident, Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Cristin L. RothfussExecutive Vice President, General Counsel
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Ryan H. WongExecutive Vice President, Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Dallan MurrayFormer Executive Vice President, Chief Customer Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 12 peers with pay on file was $16.5M. The CEO of Sarepta Therapeutics was paid $7.8M, 52% below the median.

  1. 1Exelixis
  2. 2Incyte
  3. 3PTC Therapeutics
  4. 4Halozyme Therapeutics
  5. 5Biomarin Pharmaceutical
  6. 6United Therapeutics
  7. 7Alnylam Pharmaceuticals
  8. 8Ionis Pharmaceuticals
  9. 9Ultragenyx Pharmaceutical
  10. 10Alkermes plc.
  11. 11Sarepta Therapeutics
  12. 12Neurocrine Biosciences
  13. 13Repligen
  14. 14Acadia PharmaceuticalsNot disclosed
  15. 15ArgenxNot disclosed
  16. 16Blueprint MedicinesNot disclosed
  17. 17Jazz PharmaceuticalsNot disclosed
  18. 18Vertex PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.